The Prostate Cancer, Genetic Risk, and Equitable Screening Study (ProGRESS)

Clinical Trials, Low Risk Prostate Cancer

PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives

NCT Number: NCT05926102
Phase:
Trial Summary: Prostate cancer is the most common non-skin cancer among Veterans and the second leading cause of male cancer death. Current methods of screening men for prostate cancer are inaccurate and cannot iden – see clinicaltrials.gov for information and location
Clinicaltrials.gov
Trial Sponsor(s): VA Office of Research and Development
Acronym
: ProGRESS

Pin It on Pinterest